- Home
- UTHR vs STX Comparison
UTHR vs STX Comparison
Compare UTHR & STX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- STX
- Stock Information
- Founded
- UTHR 1996
- STX 1978
- Country
- UTHR United States
- STX Singapore
- Employees
- UTHR N/A
- STX N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- STX Electronic Components
- Sector
- UTHR Health Care
- STX Technology
- Exchange
- UTHR Nasdaq
- STX Nasdaq
- Market Cap
- UTHR 14.4B
- STX 15.5B
- IPO Year
- UTHR 1999
- STX 2002
- Fundamental
- Price
- UTHR $284.73
- STX $75.78
- Analyst Decision
- UTHR Buy
- STX Buy
- Analyst Count
- UTHR 12
- STX 20
- Target Price
- UTHR $388.25
- STX $122.63
- AVG Volume (30 Days)
- UTHR 499.4K
- STX 4.8M
- Earning Date
- UTHR 04-30-2025
- STX 04-29-2025
- Dividend Yield
- UTHR N/A
- STX 3.80%
- EPS Growth
- UTHR 24.38
- STX N/A
- EPS
- UTHR 24.64
- STX 5.45
- Revenue
- UTHR $2,877,400,000.00
- STX $8,035,000,000.00
- Revenue This Year
- UTHR $11.52
- STX $37.69
- Revenue Next Year
- UTHR $6.08
- STX $12.79
- P/E Ratio
- UTHR $11.56
- STX $13.90
- Revenue Growth
- UTHR 23.63
- STX 24.17
- 52 Week Low
- UTHR $233.28
- STX $63.19
- 52 Week High
- UTHR $417.82
- STX $115.32
- Technical
- Relative Strength Index (RSI)
- UTHR 37.49
- STX 43.99
- Support Level
- UTHR $266.98
- STX $71.30
- Resistance Level
- UTHR $288.54
- STX $75.23
- Average True Range (ATR)
- UTHR 14.43
- STX 4.87
- MACD
- UTHR -0.15
- STX 0.39
- Stochastic Oscillator
- UTHR 38.23
- STX 54.38
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
About STX Seagate Technology Holdings PLC (Ireland)
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.